FDA Grants Breakthrough Device Designation for Dexcom Hospital CGM System

 

• Dexcom CGM to be evaluated for performance in the hospital and for the potential of more effective glycemic management and improved patient outcomes in the hospital setting

• Breakthrough Device Designation from the FDA is a critical milestone for in-patient Dexcom CGM use

• This designation provides a more efficient and streamlined review pathway so innovative Dexcom CGM technology can get to the hospital market faster

https://finance.yahoo.com/news/fda-grants-breakthrough-device-designation-210500678.html